FutureFuel Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FutureFuel Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $65.51M | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | $81.42M | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | $88.34M | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | $55.75M | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $75.26M | Mar 15, 2019 |
| FY2018 | Sep 30, 2017 | $77.61M | Mar 15, 2019 |
| FY2018 | Jun 30, 2017 | $68.05M | Mar 15, 2019 |
| FY2018 | Mar 31, 2017 | $54.11M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $69.37M | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $69.31M | Mar 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.74M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $243.34M | Mar 16, 2026 |
| FY2023 | Dec 31, 2023 | $92.01M | May 10, 2024 |
| FY2023 | Sep 30, 2023 | $116.75M | May 10, 2024 |
| FY2023 | Jun 30, 2023 | $85.31M | May 10, 2024 |
| FY2023 | Mar 31, 2023 | $74.18M | May 10, 2024 |
| FY2023 | Dec 31, 2022 | $117.82M | May 10, 2024 |
| FY2023 | Sep 30, 2022 | $118.14M | May 10, 2024 |
| FY2023 | Jun 30, 2022 | $117.80M | May 10, 2024 |
| FY2023 | Mar 31, 2022 | $42.26M | May 10, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.43M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $19.64M | Mar 16, 2026 |
| FY2023 | Dec 31, 2023 | $24.08M | May 10, 2024 |
| FY2023 | Sep 30, 2023 | $3.87M | May 10, 2024 |
| FY2023 | Jun 30, 2023 | ($8.59M) | May 10, 2024 |
| FY2023 | Mar 31, 2023 | $21.62M | May 10, 2024 |
| FY2023 | Dec 31, 2022 | $15.19M | May 10, 2024 |
| FY2023 | Sep 30, 2022 | $19.99M | May 10, 2024 |
| FY2023 | Jun 30, 2022 | $977.0K | May 10, 2024 |
| FY2023 | Mar 31, 2022 | ($7.16M) | May 10, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($49.40M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $15.50M | Mar 16, 2026 |
| FY2023 | Dec 31, 2023 | $23.38M | May 10, 2024 |
| FY2023 | Sep 30, 2023 | $2.78M | May 10, 2024 |
| FY2023 | Jun 30, 2023 | ($9.86M) | May 10, 2024 |
| FY2023 | Mar 31, 2023 | $21.08M | May 10, 2024 |
| FY2023 | Dec 31, 2022 | $14.93M | May 10, 2024 |
| FY2023 | Sep 30, 2022 | $15.78M | May 10, 2024 |
| FY2023 | Jun 30, 2022 | ($3.10M) | May 10, 2024 |
| FY2023 | Mar 31, 2022 | ($12.40M) | May 10, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($52.99M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $6.37M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $27.37M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $17.55M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $12.90M | May 10, 2024 |
| FY2022 | Dec 31, 2020 | $22.34M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $65.31M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $63.44M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $9.89M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $36.52M | Mar 15, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.87M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $3.99M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $4.40M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $3.42M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $3.48M | May 10, 2024 |
| FY2022 | Dec 31, 2020 | $2.99M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $3.19M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $3.52M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $3.66M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $2.72M | Mar 15, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.70M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $9.28M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $9.21M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $8.03M | Mar 31, 2025 |
| FY2011 | Dec 31, 2011 | $10.14M | Mar 15, 2012 |
| FY2011 | Dec 31, 2010 | $9.13M | Mar 15, 2012 |
| FY2011 | Dec 31, 2009 | $9.60M | Mar 15, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($28.74M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $24.80M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $21.30M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $52.45M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $44.08M | May 10, 2024 |
| FY2022 | Dec 31, 2020 | $96.40M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $34.64M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $85.61M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $39.35M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $90.98M | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.25M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $14.67M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $6.02M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $4.78M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $1.46M | May 10, 2024 |
| FY2022 | Dec 31, 2020 | $4.46M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $6.97M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $4.87M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $3.58M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $4.50M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $192.24M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $247.69M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $367.08M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $355.97M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $344.33M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $441.30M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $586.51M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $471.16M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $425.56M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $529.04M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.53M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $41.87M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $57.20M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $72.97M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $55.40M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $69.42M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $119.41M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $82.08M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $73.97M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $196.23M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $154.71M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $205.82M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $309.88M | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | $283.00M | Mar 16, 2026 |
| FY2024 | Dec 31, 2021 | $288.93M | Mar 31, 2025 |
| FY2023 | Dec 31, 2020 | $371.88M | May 10, 2024 |
| FY2022 | Dec 31, 2019 | $467.10M | Mar 14, 2023 |
| FY2021 | Dec 31, 2018 | $389.08M | Mar 15, 2022 |
| FY2020 | Dec 31, 2017 | $351.60M | Mar 16, 2021 |
| FY2019 | Dec 31, 2016 | $332.81M | Mar 13, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($49.07M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $383.0K | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $27.39M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $508.0K | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $6.30M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $89.46M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $184.63M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $106.95M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $61.20M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $48.18M | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.32M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $109.54M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $219.44M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $175.64M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $137.52M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $198.12M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $243.33M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $214.97M | Mar 13, 2020 |
| FY2019 | Dec 31, 2017 | $114.63M | Mar 13, 2020 |
| FY2019 | Dec 31, 2016 | $199.27M | Mar 13, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2023 | Dec 31, 2023 | 0 | May 10, 2024 |
| FY2023 | Sep 30, 2023 | 0 | May 10, 2024 |
| FY2023 | Jun 30, 2023 | 0 | May 10, 2024 |
| FY2023 | Mar 31, 2023 | 0 | May 10, 2024 |
| FY2023 | Dec 31, 2022 | 0 | May 10, 2024 |
| FY2023 | Sep 30, 2022 | 0 | May 10, 2024 |
| FY2023 | Jun 30, 2022 | 0 | May 10, 2024 |
| FY2023 | Mar 31, 2022 | 0 | May 10, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2023 | Dec 31, 2023 | 0 | May 10, 2024 |
| FY2023 | Sep 30, 2023 | 0 | May 10, 2024 |
| FY2023 | Jun 30, 2023 | 0 | May 10, 2024 |
| FY2023 | Mar 31, 2023 | 0 | May 10, 2024 |
| FY2023 | Dec 31, 2022 | 0 | May 10, 2024 |
| FY2023 | Sep 30, 2022 | 0 | May 10, 2024 |
| FY2023 | Jun 30, 2022 | 0 | May 10, 2024 |
| FY2023 | Mar 31, 2022 | 0 | May 10, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43.86M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 43.80M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 43.76M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 43.76M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | 43.74M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | 43.74M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 43.74M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 43.74M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 43.74M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 43.75M | Mar 16, 2018 |